How KYMRIAH May Help
Relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) treatment, individualized just for you
KYMRIAH® (tisagenlecleucel) is not a pill, chemotherapy, or transplant. KYMRIAH is an individualized treatment made just for you, using the inner strength of your own immune system to fight your cancer. By reprogramming your T cells, KYMRIAH enhances their ability to detect and destroy your B cells, including those with cancer in them.
B cells, along with other cells, make up your body’s immune system. They defend the body by producing antibodies; T cells, along with other cells, make up your body’s immune system. They are natural defenders that detect and destroy possible threats such as infected or cancerous cells.
Will KYMRIAH work for me?
The goal of KYMRIAH is to put your cancer into long-term remission. Many patients with r/r DLBCL have had lasting responses to treatment. Keep in mind that every patient is unique, and responses to treatment may vary depending on the individual.
Remission, the signs of your cancer have disappeared or else your disease is under control. It does not necessarily mean a cure.
In a global, phase 2 pivotal study (JULIET), high rates of long-lasting responses were seen with the use of KYMRIAH.
Data from the 40.3-month median follow-up of JULIET are not included in the prescribing information and should be interpreted carefully.
